Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Jordan, Karin [VerfasserIn]   i
Titel:Supportive treatments for patients with cancer
Werktitel:Supportive Therapie bei onkologischen Patienten
Verf.angabe:Karin Jordan, Petra Feyer, Ulrike Höller, Hartmut Link, Bernhard Wörmann, Franziska Jahn
Jahr:2017
Umfang:7 S.
Fussnoten:Aus dem Deutschen übersetzt ; Gesehen am 16.08.2018
Titel Quelle:Enthalten in: Deutsches Ärzteblatt international
Ort Quelle:Köln : Dt. Ärzte-Verl., 2006
Jahr Quelle:2017
Band/Heft Quelle:114(2017), 27-28, Seite 481-487
ISSN Quelle:1866-0452
Abstract:BACKGROUND: For the treatment of patients with cancer to be successful and well-tolerated, the complications and side effects of the disease and its treatment must be treated and limited as far as possible. Summarized recommendations based on the constantly increasing evidence in the area of supportive care must be defined, standardized, and communicated. METHODS: We systematically reviewed the literature on the topics of anemia, neutropenia, nausea/vomiting, diarrhea, oral mucositis, skin toxicity, and peripheral neurotoxicity induced by cancer treatment, as well as osseous complications, extravasation, and side effects of radiotherapy. Recommendations were approved in a moderated, formalized consensus procedure. RESULTS: In patients suffering from chemotherapy-induced anemia, the administration of agents that stimulate erythropoiesis can be considered. This can potentially improve these patients' quality of life and lessen the frequency of blood transfusions, but it can also lead to thromboembolic complications and arterial hypertension. If only a single individual risk factor is present in a patient whose risk of febrile neutropenia is estimated at 10-20%, there is no obligatory indication for the administration of granulocyte-colony stimulating factor. Antiemetic treatment before carboplatin is given can consist of a neurokinin-1 receptor antagonist along with a setron and dexamethasone. Duloxetine is recommended for the treatment of neuropathic pain. Sensorimotor training is effective in the treatment of chemotherapy-induced peripheral neuropathy and can already be given at the same time as the chemotherapy. Women with bony metastases of breast cancer who have been taking zoledronate at four-week intervals for a year should take it at 12-week intervals from then onward in order to lessen the likelihood of osseus complications. There is no evidence for any effective prophylactic treatment of chemotherapy-induced diarrhea. CONCLUSION: Supportive measures are an integral component of all oncological treatments. More research is needed to determine how side effects can be lessened and prevented.
DOI:doi:10.3238/arztebl.2017.0481
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Kostenfrei: Volltext ; Verlag: http://dx.doi.org/10.3238/arztebl.2017.0481
 Kostenfrei: Volltext: https://www.aerzteblatt.de/int/archive/article?id=192251
 DOI: https://doi.org/10.3238/arztebl.2017.0481
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1580133231
Verknüpfungen:→ Zeitung

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68296173   QR-Code
zum Seitenanfang